HDGF and ADAM9 are novel molecular staging biomarkers, prognostic biomarkers and predictive biomarkers for adjuvant chemotherapy in surgically resected stage I non-small cell lung cancer
Crossref DOI link: https://doi.org/10.1007/s00432-014-1687-2
Published Online: 2014-04-27
Published Print: 2014-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhang, Jun
Chen, Ning
Qi, Juan
Zhou, Baosen
Qiu, Xueshan
Text and Data Mining valid from 2014-04-27